D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study

Table 1 Glycemia, insulinemia, Homeostatic Model Assessment (HOMA) index, D-chiro-inositol (DCI), myo-inositol (MI) and Body Mass Index (BMI) values at baseline in volunteers V1-V10

Volunteers	glycemia mg/dl	insulinemia μIU/ml	HOMA index (^a)	DCI μmol/l	MI μmol/l	BMI
V1	117	32.16	9.3	0.15	13.0	29.7
V2	101	4.58	1.15	0.16	13.5	27.3
V3	109	5.60	1.5	0.16	14.3	29.4
V4	110	4.18	1.14	0.25	15.0	27.0
V5	88	6.91	1.5	0.29	16.4	23.4
V6	86	9.66	2.06	0.49	18.0	27.6
V7	95	8.93	2.09	0.70	18.0	22.9
V8	93	8.70	2	0.71	20.8	25.8
V9	110	7.19	1.96	0.90	20.8	33.6
V10	90	5.82	1.29	0.90	21.0	30.9
Percentiles
25	90.8	5.7	1.3	0.18	14.5	26.1
50	98.0	7.1	1.5	0.39	17.2	27.5
75	109.8	8.9	2.1	0.71	20.8	29.6

Individual results and Percentiles (25th, 50th and 75th) of Glycemia, Insulinemia, BMI Body Mass Index, HOMA Homeostatic Model Assessment, DCI D-chiro-inositol and MI myo-inositol in the Study cohort of 10 volunteers (V1-V10)
(^a) arbitrary units

ISSN: 2051-4190